Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review

The most prevalent and deadly primary malignant glioma in adults is glioblastoma (GBM), which has a median survival time of about 15 months. Despite the standard of care for glioblastoma, which includes gross total resection, high-dose radiation, and temozolomide chemotherapy, this tumor is still on...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Masoumeh, Jahanbakhshi, Amin, Finocchi Ghersi, Sebastiano, Giaccherini, Lucia, Botti, Andrea, Cavallieri, Francesco, Rossi, Jessica, Iori, Federico, Iotti, Cinzia, Ciammella, Patrizia, Nabiuni, Mohsen, Gomar, Marzieh, Rezaie, Omid, Cozzi, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953849/
https://www.ncbi.nlm.nih.gov/pubmed/36831702
http://dx.doi.org/10.3390/brainsci13020159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953849/
https://www.ncbi.nlm.nih.gov/pubmed/36831702
http://dx.doi.org/10.3390/brainsci13020159

Ejemplares similares